A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer.
- Published in:
- 2010
- By:
- Publication type:
- Report
Works by Ross, Robert W.
Results: 12
1
2
A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
3
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4777, doi. 10.1002/cncr.27416
- By:
- Publication type:
- Article
5
Activity of Dutasteride Plus Ketoconazole in Castration-Refractory Prostate Cancer After Progression on Ketoconazole Alone.
- Published in:
- Clinical Genitourinary Cancer, 2009, v. 7, n. 3, p. E90, doi. 10.3816/CGC.2009.n.030
- By:
- Publication type:
- Article
6
Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.
- Published in:
- BJU International, 2011, v. 108, n. 7, p. 1086, doi. 10.1111/j.1464-410X.2010.10037.x
- By:
- Publication type:
- Article
7
Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer.
- Published in:
- BJU International, 2008, v. 101, n. 3, p. 308, doi. 10.1111/j.1464-410X.2007.07331.x
- By:
- Publication type:
- Article
8
Time to Prostate-Specific Antigen Nadir Independently Predicts Overall Survival in Patients Who Have Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen-Deprivation Therapy.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 5, p. 981, doi. 10.1002/cncr.24064
- By:
- Publication type:
- Article
9
Efficacy of Androgen Deprivation Therapy (ADT) in Patients With Advanced Prostate Cancer.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 6, p. 1247, doi. 10.1002/cncr.23304
- By:
- Publication type:
- Article
10
A Phase 2 Study of Carboplatin Plus Docetaxel in Men With Metastatic Hormone-refractory Prostate Cancer Who Are Refractory to Docetaxel.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 3, p. 521, doi. 10.1002/cncr.23195
- By:
- Publication type:
- Article
11
T HE U SE OF E MERGENCY M EDICAL D ISPATCH P ROTOCOLS TO R EDUCE THE N UMBER OF I NAPPROPRIATE S CENE R ESPONSES M ADE BY A DVANCED L IFE S UPPORT P ERSONNEL.
- Published in:
- Prehospital Emergency Care, 2000, v. 4, n. 2, p. 186, doi. 10.1080/10903120090941489
- By:
- Publication type:
- Article
12
Hormone-Refractory Prostate Cancer: Choosing the Appropriate Treatment Option.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 2, p. 185
- By:
- Publication type:
- Article